Matthew McGrew, group chief financial officer of Danaher’s diagnostics and dental platforms, will transition to the role of CFO at the Washington, D.C.-based company, effective Jan. 1, 2019.
Danaher said McGrew will succeed Daniel Comas, who is slated to retire after a nearly three-decade career at the manufacturing firm.
Comas joined Danaher in 1991 and was named CFO in April 2005. The company has seen a more than two-fold increase in revenues to $18 billion and a four-fold growth in market capitalization to approximately $70 billion since Comas took over as CFO.
McGrew is responsible for Danaher’s life sciences, product identification, diagnostic and dental products in his current position. He previously served as vice president of investor relations and director of mergers and acquisitions finance at the company.
McGrew joined Danaher from professional services firm KPMG, where he worked as a director in the transaction services group.
He has a bachelor's degree in accounting from DePaul University.